Filing Details
- Accession Number:
- 0001209191-21-008129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-05 16:51:16
- Reporting Period:
- 2021-02-03
- Accepted Time:
- 2021-02-05 16:51:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1404644 | Neoleukin Therapeutics Inc. | NLTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1843189 | Carl Walkey | Co Neoleukin Therapeutics, Inc. 360-1616 Eastlake Avenue East Seattle WA 98102 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-03 | 2,400 | $13.23 | 1,383,562 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Billionaire Hedge Funds
